Sunitinib Malate Market By Disease 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Sunitinib Malate Market
Sunitinib Malate Market: By Disease (Pancreatic Neuroendocrine Tumors & Kidney Cancer) & By Region (Europe, North America, Asia-Pacific & Rest of the World (RoW)) - Forecast(2018 - 2023)
Report Code : HCR 0388
Updated Date: 15 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Sunitinib Malate Market – Overview
2. Executive Summary 
3. Sunitinib Malate Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Sunitinib Malate Market– Forces
   4.1. Drivers
      4.1.1. Increasing prevalence of pancreatic cancer
   4.2. Restraints
      4.2.1. Higher cost of Sutent
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Use of sunitinib malate capsules
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Sunitinib Malate Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Sunitinib Malate Market, By Cancer
   6.1. Pancreatic Neuroendocrine Tumors
   6.2. Kidney Cancer
   6.3. Gastrointestinal stromal tumor (GIST)
7. Sunitinib Malate Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America 
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Sunitinib Malate – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Pfizer Incorporation.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Sunitinib, developed and marketed as Sutent by Pfizer Inc and previously known as SU11248, is a small-molecule medicine which has to be administered orally and has been proven to be effective in blocking multiple receptor tyrosine kinases (RTKs). Sunitinib was the first cancer drug simultaneously approved for two different indications, namely renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). Global advancement of technology and increasing prevalence of pancreatic cancer are the prime growth drivers of the global sunitinib malate market. Coupled with increasing awareness about pancreatic cancer in emerging economies such as China, India and others is expected to create new opportunities for the sunitinib malate market. However, higher cost of research and development, and high cost of sutent are the key restraints for the sunitinib malate market.

Sunitinib Malate Market
 
Geographically, North America dominates the sunitinib malate market driven by best in class infrastructure, easy access to healthcare, higher awareness about pancreatic cancer, higher technological knowledge and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as the second and third largest market for sunitinib malate market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, increased spending, and increasing awareness amongst population in developing nations such as China and India in this region.

This report identifies the global sunitinib malate market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the sunitinib malate market.

This report segments the sunitinib malate market on the basis of cancer type and regional market as follows:
  • This report on the sunitinib malate market is segmented on the basis of major cancer types which can be treated with sunitinib malate, some of the major cancer types covered in this report are as follows: Pancreatic Neuroendocrine Tumors (Pancreatic cancer), Gastrointestinal stromal tumor (GIST) and Kidney Cancer
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Sunitinib Malate market. Some of the major companies’ profiles in detail are as follows:
  • Pfizer Inc.
List of Table s

Table 1: Sunitinib Malate Market Overview 2017-2023
Table 2: Sunitinib Malate Market Leader Analysis 2017-2018 (US$)
Table 3: Sunitinib Malate Market Product Analysis 2017-2018 (US$)
Table 4: Sunitinib Malate Market End User Analysis 2017-2018 (US$)
Table 5: Sunitinib Malate Market Patent Analysis 2013-2018* (US$)
Table 6: Sunitinib Malate Market Financial Analysis 2017-2018 (US$)
Table 7: Sunitinib Malate Market Driver Analysis 2017-2018 (US$)
Table 8: Sunitinib Malate Market Challenges Analysis 2017-2018 (US$)
Table 9: Sunitinib Malate Market Constraint Analysis 2017-2018 (US$)
Table 10: Sunitinib Malate Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Sunitinib Malate Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Sunitinib Malate Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Sunitinib Malate Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Sunitinib Malate Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Sunitinib Malate Market Value Chain Analysis 2017-2018 (US$)
Table 16: Sunitinib Malate Market Pricing Analysis 2018-2023 (US$)
Table 17: Sunitinib Malate Market Opportunities Analysis 2018-2023 (US$)
Table 18: Sunitinib Malate Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Sunitinib Malate Market Supplier Analysis 2017-2018 (US$)
Table 20: Sunitinib Malate Market Distributor Analysis 2017-2018 (US$)
Table 21: Sunitinib Malate Market Trend Analysis 2017-2018 (US$)
Table 22: Sunitinib Malate Market Size 2017 (US$)
Table 23: Sunitinib Malate Market Forecast Analysis 2018-2023 (US$)
Table 24: Sunitinib Malate Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Sunitinib Malate Market, Revenue & Volume, By Cancer, 2018-2023 ($)
Table 26: Sunitinib Malate Market By Cancer, Revenue & Volume, By Pancreatic Neuroendocrine Tumors, 2018-2023 ($)
Table 27: Sunitinib Malate Market By Cancer, Revenue & Volume, By Kidney Cancer, 2018-2023 ($)
Table 28: Sunitinib Malate Market By Cancer, Revenue & Volume, By Gastrointestinal stromal tumor, 2018-2023 ($)
Table 29: North America Sunitinib Malate Market, Revenue & Volume, By Cancer, 2018-2023 ($)
Table 30: South america Sunitinib Malate Market, Revenue & Volume, By Cancer, 2018-2023 ($)
Table 31: Europe Sunitinib Malate Market, Revenue & Volume, By Cancer, 2018-2023 ($)
Table 32: APAC Sunitinib Malate Market, Revenue & Volume, By Cancer, 2018-2023 ($)
Table 33: Middle East & Africa Sunitinib Malate Market, Revenue & Volume, By Cancer, 2018-2023 ($)
Table 34: Russia Sunitinib Malate Market, Revenue & Volume, By Cancer, 2018-2023 ($)
Table 35: Israel Sunitinib Malate Market, Revenue & Volume, By Cancer, 2018-2023 ($)
Table 36: Top Companies 2017 (US$)Sunitinib Malate Market, Revenue & Volume
Table 37: Product Launch 2017-2018Sunitinib Malate Market, Revenue & Volume
Table 38: Mergers & Acquistions 2017-2018Sunitinib Malate Market, Revenue & Volume


List of Figures

Figure 1: Overview of Sunitinib Malate Market 2017-2023
Figure 2: Market Share Analysis for Sunitinib Malate Market 2017 (US$)
Figure 3: Product Comparison in Sunitinib Malate Market 2017-2018 (US$)
Figure 4: End User Profile for Sunitinib Malate Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Sunitinib Malate Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Sunitinib Malate Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Sunitinib Malate Market 2017-2018
Figure 8: Ecosystem Analysis in Sunitinib Malate Market 2017
Figure 9: Average Selling Price in Sunitinib Malate Market 2017-2023
Figure 10: Top Opportunites in Sunitinib Malate Market 2017-2018
Figure 11: Market Life Cycle Analysis in Sunitinib Malate Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy CancerSunitinib Malate Market Revenue, 2018-2023 ($)
Figure 13: Global Sunitinib Malate Market - By Geography
Figure 14: Global Sunitinib Malate Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 15: Global Sunitinib Malate Market CAGR, By Geography, 2018-2023 (%)
Figure 16: North America Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 17: US Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 18: US GDP and Population, 2017-2018 ($)
Figure 19: US GDP – Composition of 2017, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2017-2018 ($)
Figure 21: Canada Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 22: Canada GDP and Population, 2017-2018 ($)
Figure 23: Canada GDP – Composition of 2017, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 25: Mexico Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 26: Mexico GDP and Population, 2017-2018 ($)
Figure 27: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 29: South America Sunitinib Malate Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 30: Brazil Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 31: Brazil GDP and Population, 2017-2018 ($)
Figure 32: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 34: Venezuela Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 35: Venezuela GDP and Population, 2017-2018 ($)
Figure 36: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 38: Argentina Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 39: Argentina GDP and Population, 2017-2018 ($)
Figure 40: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 42: Ecuador Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 43: Ecuador GDP and Population, 2017-2018 ($)
Figure 44: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 46: Peru Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 47: Peru GDP and Population, 2017-2018 ($)
Figure 48: Peru GDP – Composition of 2017, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 50: Colombia Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 51: Colombia GDP and Population, 2017-2018 ($)
Figure 52: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 54: Costa Rica Sunitinib Malate Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 55: Costa Rica GDP and Population, 2017-2018 ($)
Figure 56: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 58: Europe Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 59: U.K Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 60: U.K GDP and Population, 2017-2018 ($)
Figure 61: U.K GDP – Composition of 2017, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 63: Germany Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 64: Germany GDP and Population, 2017-2018 ($)
Figure 65: Germany GDP – Composition of 2017, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 67: Italy Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 68: Italy GDP and Population, 2017-2018 ($)
Figure 69: Italy GDP – Composition of 2017, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 71: France Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 72: France GDP and Population, 2017-2018 ($)
Figure 73: France GDP – Composition of 2017, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2017-2018 ($)
Figure 75: Netherlands Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 76: Netherlands GDP and Population, 2017-2018 ($)
Figure 77: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 79: Belgium Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 80: Belgium GDP and Population, 2017-2018 ($)
Figure 81: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 83: Spain Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 84: Spain GDP and Population, 2017-2018 ($)
Figure 85: Spain GDP – Composition of 2017, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 87: Denmark Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 88: Denmark GDP and Population, 2017-2018 ($)
Figure 89: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 91: APAC Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 92: China Sunitinib Malate Market Value & Volume, 2018-2023
Figure 93: China GDP and Population, 2017-2018 ($)
Figure 94: China GDP – Composition of 2017, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2017-2018 ($)Sunitinib Malate Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 96: Australia Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 97: Australia GDP and Population, 2017-2018 ($)
Figure 98: Australia GDP – Composition of 2017, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 100: South Korea Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 101: South Korea GDP and Population, 2017-2018 ($)
Figure 102: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 104: India Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 105: India GDP and Population, 2017-2018 ($)
Figure 106: India GDP – Composition of 2017, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2017-2018 ($)
Figure 108: Taiwan Sunitinib Malate Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 109: Taiwan GDP and Population, 2017-2018 ($)
Figure 110: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 112: Malaysia Sunitinib Malate Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 113: Malaysia GDP and Population, 2017-2018 ($)
Figure 114: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 116: Hong Kong Sunitinib Malate Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 117: Hong Kong GDP and Population, 2017-2018 ($)
Figure 118: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 120: Middle East & Africa Sunitinib Malate Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121: Russia Sunitinib Malate Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122: Russia GDP and Population, 2017-2018 ($)
Figure 123: Russia GDP – Composition of 2017, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 125: Israel Sunitinib Malate Market Value & Volume, 2018-2023 ($)
Figure 126: Israel GDP and Population, 2017-2018 ($)
Figure 127: Israel GDP – Composition of 2017, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 129: Entropy Share, By Strategies, 2017-2018* (%)Sunitinib Malate Market
Figure 130: Developments, 2017-2018*Sunitinib Malate Market
Figure 131: Company 1 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 132: Company 1 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 133: Company 1 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 134: Company 2 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 135: Company 2 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 136: Company 2 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 137: Company 3 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 138: Company 3 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 139: Company 3 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 140: Company 4 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 141: Company 4 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 142: Company 4 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 143: Company 5 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 144: Company 5 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 145: Company 5 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 146: Company 6 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 147: Company 6 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 148: Company 6 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 149: Company 7 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 150: Company 7 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 151: Company 7 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 152: Company 8 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 153: Company 8 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 154: Company 8 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 155: Company 9 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 156: Company 9 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 157: Company 9 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 158: Company 10 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 159: Company 10 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 160: Company 10 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 161: Company 11 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 162: Company 11 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 163: Company 11 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 164: Company 12 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 165: Company 12 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 166: Company 12 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 167: Company 13 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 168: Company 13 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 169: Company 13 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 170: Company 14 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 171: Company 14 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 172: Company 14 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Figure 173: Company 15 Sunitinib Malate Market Net Revenue, By Years, 2017-2018* ($)
Figure 174: Company 15 Sunitinib Malate Market Net Revenue Share, By Business segments, 2017 (%)
Figure 175: Company 15 Sunitinib Malate Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll